Trial Profile
Comparative Study Evaluating the Immunogenicity and Safety of MeMuRu-OKA Vaccine and Measles-mumps-rubella Vaccine (Priorix™) Co-administered With Varicella Vaccine (Varilrix™) in Children Primed With Measles-mumps-rubella Vaccine
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Jun 2023
Price :
$35
*
At a glance
- Drugs MMR-varicella zoster virus vaccine (Primary) ; Measles mumps and rubella virus vaccine; Varicella zoster virus vaccine live
- Indications Chickenpox; Measles; Mumps; Rubella; Varicella zoster virus infections
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline; GSK
- 14 Jan 2009 Results were published in Vaccine.
- 29 Jul 2008 Status changed from in progress to completed as reported by ClinicalTrials.gov.
- 09 Jul 2007 New trial record.